Q
Quanlin Li
Researcher at Cedars-Sinai Medical Center
Publications - 54
Citations - 2051
Quanlin Li is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Coronary artery disease & Heart failure. The author has an hindex of 20, co-authored 48 publications receiving 1697 citations. Previous affiliations of Quanlin Li include United States Environmental Protection Agency & Peking University.
Papers
More filters
Journal ArticleDOI
A multiple imputation method for incomplete correlated ordinal data using multivariate probit models
TL;DR: A Markov chain Monte Carlo method to conduct multiple imputation for incomplete correlated ordinal data using the multivariate probit model is proposed.
Journal ArticleDOI
Clinical factors associated with the development of Crohn's disease in inflammatory bowel disease-unclassified patients undergoing ileal pouch-anal anastomosis
Sharon Z. Koh,Karen Zaghiyan,Quanlin Li,Shervin Rabizadeh,Gil Y. Melmed,Stephan R. Targan,Phillip Fleshner +6 more
TL;DR: The sole clinical predictor for the development of CD after IPAA was younger age at disease onset even after controlling for relevant clinical factors in a multivariate analysis, which increased the odds of developing CD increased by 4% for each year that IBDU was diagnosed at a younger age.
Journal ArticleDOI
Maladaptive left ventricular remodeling in women: An analysis from the Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction study
Omeed Elboudwarej,Janet Wei,Navid Darouian,Galen Cook-Wiens,Quanlin Li,Louise Thomson,John W. Petersen,R. David Anderson,Puja K. Mehta,Chrisandra Shufelt,Daniel S. Berman,Babak Azarbal,Bruce Samuels,Eileen M. Handberg,George Sopko,Carl J. Pepine,C. Noel Bairey Merz +16 more
TL;DR: Among women with signs and symptoms of ischemia without obstructive CAD, absence of CMD, and preserved LVEF, isolated elevated LVEDP is associated with a significantly higher systolic and diastolic blood pressure, higher LV mass-to-volume ratio and lower LV EDVI.
Journal Article
The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma.
TL;DR: This study focuses on the feasibility of this novel regulatory cell death mechanism in ccRCC treatment and further constructed a prognostic model, and provides new insights into the development and clinical application of targeting cuprotosis pathway.
Journal ArticleDOI
The Integrated Web Portal for Escalation with Overdose Control (EWOC).
Haibin Wang,Mourad Tighiouart,Shao-Chi Huang,Dror Berel,Galen Cook-Wiens,Catherine Bresee,Quanlin Li,Andre Rogatko +7 more
TL;DR: A novel web portal for the cancer phase I clinical trial design method Escalation with Overdose Control (EWOC) is presented, developed using open source software: PHP, JQuery, R and OpenBUGS.